A Case Series of Myocarditis Following Third (Booster) Dose of COVID-19 Vaccination: Magnetic Resonance Imaging Study

BACKGROUND: Myocarditis has been reported following the first two doses of Pfizer-BNT162b2 messenger RNA (mRNA) COVID-19 vaccination. Administration of a third dose (booster) of the vaccine was initiated recently in Israel. OBJECTIVE: The aim of this study was to describe the characteristics of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiyovich, Arthur, Witberg, Guy, Aviv, Yaron, Kornowski, Ran, Hamdan, Ashraf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930918/
https://www.ncbi.nlm.nih.gov/pubmed/35310989
http://dx.doi.org/10.3389/fcvm.2022.839090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930918/
https://www.ncbi.nlm.nih.gov/pubmed/35310989
http://dx.doi.org/10.3389/fcvm.2022.839090

Ejemplares similares